The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study on the efficacy and toxicity of cabozantinib in recurrent/metastatic salivary gland cancer patients.
 
Wim van Boxtel
No Relationships to Disclose
 
Maike Uijen
No Relationships to Disclose
 
Chantal Driessen
No Relationships to Disclose
 
Sjoert Pegge
No Relationships to Disclose
 
Stefan M. Willems
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Pfizer; Roche
Speakers' Bureau - Bristol-Myers Squibb; MSD; Pfizer; Roche
 
Marianne Jonker
No Relationships to Disclose
 
Tim Dijkema
No Relationships to Disclose
 
Ilse van Engen - van Grunsven
No Relationships to Disclose
 
Carla M.L.- Van Herpen
Consulting or Advisory Role - Bayer (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); MSD (Inst); Regeneron (Inst)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Sanofi (Inst)